Actions

Emerging strategies and options: Difference between revisions

From MalariaETC

No edit summary
No edit summary
Line 6: Line 6:


{| class="wikitable" style="widthe:90%; border-style: solid; border-width: 4px; color:black"
{| class="wikitable" style="widthe:90%; border-style: solid; border-width: 4px; color:black"
|colspan="1" style = "font-size:100%; color:blasck; background: FFFAFA"|<span style="color:navy>'''Emerging Strategies'''
|colspan="1" style = "font-size:100%; color:blasck; background: FFFAFA"|<span style="color:navy>'''Emerging Strategies'''</span>





Revision as of 14:36, 13 September 2024


Navigation
Go Back



Emerging Strategies


Multiplexed detection strategies may be used in some circumstances to optimase performance for local need:
(a) Where both P.falciparum and P.vivax are highly prevalent, tests may be compiled the identify each with specificity - P.falciparum (HRP2) and P.vivax (Pv-pLDH). This can offer some advantages in detecting dual infection by the two species when compared to using a pan-malarial antibody.


to distinguish between infections by P. falciparum and P. vivax. Alternatively, tests can be multiplexed to select for Pf-pLDH and HRP2, which yields highly sensitive indications for falciparum malaria. [16] Multiplexed RDTs have also proven to be efficacious in discriminating between distinct diseases with non-specific symptomatic presentations.